Prediction of Atrial Fibrillation Using Polygenic Risk Score
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 800 participants.
Also called NCT07641582
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 800 participants
- Sponsor
- Registry
-
NCT07641582
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Recruiting
Technical summary
Registry record NCT07641582. Allocation not applicable; no masking; primary purpose diagnostic. Start 2024-11-19 (actual); primary completion 2026-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prediction of Atrial Fibrillation Using Polygenic Risk Score
- Acronym
- PREGENCE
- Condition
- Atrial Fibrillation (AF)
- Intervention (Device)
- 7-day continuous ECG (electrocardiogram) patch monitor
- Intervention (Device)
- Six-lead handheld electrocardiogram device
- Intervention (Genetic)
- SNP array genotyping
- Lead sponsor
- Seoul St. Mary's Hospital
Record details
- Record id
cardio:ct-nct07641582- Content hash
69375e709b0e211c2a30d8c8c9a146761e7ec5171179179201b0a93765c4700f